Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Allogeneic CD19 CAR-T cells
Locations
1
China
Li Yu
Shenzhen, Guangdong, China
Start Date
February 5, 2021
Primary Completion Date
February 1, 2024
Completion Date
February 1, 2024
Last Updated
December 20, 2021
NCT07356154
NCT05512169
NCT06756321
NCT06006403
NCT04874480
NCT04139434
Lead Sponsor
Shenzhen University General Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions